Experts are calling it the biggest breakthrough in pancreatic cancer treatment for decades - a daily pill that appears to shrink and possibly even eliminate tumours in some patients with one of the deadliest and hardest-to-treat cancers.
Cancer became undetectable on scans in one in 12 of the patients given daraxonrasib along with chemotherapy in early medical trials.
Tumours stopped growing in almost all of the 61 participants who had recently been diagnosed with advanced pancreatic cancer that had spread to other parts of the body.
But doctors stress it is a long way from knowing how long it might keep the disease at bay and should not be seen as a cure.
Cancer Research UK called it "the biggest leap forward in decades" for pancreatic cancer patients.
The charity's Dr Sam Godfrey told BBC News that the results were incredibly exciting. "What this new drug has done is it's found a way of drugging the undruggable.
"We are finally seeing progress in pancreatic cancer which is so long overdue."
Pancreatic cancer is notoriously hard to treat and has the lowest survival rate of all common cancers in the UK.
Although chemotherapy can shrink tumours a bit, the cancer often grows again.
Most patients with advanced disease survive months, not years.